PostEra vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-18
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionPostEraIsomorphic Labs
PricingContact for pricingContact for pricing
Lead Discovery ApproachActive learning with multi-property optimizationAlphaFold-based protein-ligand simulation
Human-in-the-loopYes, medicinal chemists requiredYes, collaboration model
Best ForAccelerating Design-Make-Test cycleLarge-scale lead optimization with digital biology
Latest MilestoneNo recent newsSeries B (Feb 2026) + Johnson & Johnson deal (Jan 2026)

Choose PostEra if your team needs synthesis-aware medicinal chemistry with active learning and transparent partnership track record. Choose Isomorphic Labs if you are a large pharma seeking an AlphaFold-powered, simulation-first partner for ambitious discovery programs—but be prepared for a full collaboration model with higher barriers to entry.

PostEra
PostEra

AI-first biotech pairing Proton's machine-learning medicinal chemistry with synthesis-aware molecule design.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs uses AI drug discovery models to design novel molecules and predict how candidate drugs will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
19 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
—
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Proton AI platform for medicinal chemistry
Machine-learning medicinal chemistry models for small molecule design
AI-driven retrosynthetic analysis with synthetic route proposals
Synthesis-aware molecular design
Multi-property optimization across potency, selectivity, and ADME
Active learning to prioritize the most informative wet-lab experiments
Human-in-the-loop medicinal chemistry decision support
Paired drug discovery programs run with pharma partners
Applied from target identification through clinical development
Used internally on PostEra's own drug pipeline
Proton-powered AI Lab run under the Pfizer collaboration
Chemistry foundation models for small molecules
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Built on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Announced a new path to making medicines with AI
Series B announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Founded by Demis Hassabis, who serves as CEO

What real users say: PostEra vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

PostEra

4 mentions across 1 sources · 50% positive — mixed (averaged across 1 source)

Lemmy

What users praise

  • • Transparent AI with publications and validated partnerships.
  • • Proprietary chemistry foundation models for accurate predictions.
  • • Active learning reduces experimental iterations and costs.
  • • State-of-the-art retrosynthetic analysis suggests reliable synthesis routes.

What frustrates them

  • • Complete lack of user reviews or community feedback.
  • • Pricing is opaque, potentially excluding smaller organizations.
  • • Highly specialized, with no utility outside medicinal chemistry.
  • • No integration with common lab tools or platforms listed.

Researched Jul 3, 2026

Isomorphic Labs

No verifiable community signal. We scanned public discussion on Oct 14, 2026 and found posts matching the name “Isomorphic Labs”, but could not establish that they are about this product rather than something else sharing its name. Rather than publish a score built on the wrong subject, we publish none.

Who should pick which

  • Large pharma innovation lab with established experimental capacity
    Pick: PostEra

    PostEra's Proton AI accelerates the Design-Make-Test cycle with retrosynthetic analysis and active learning, fitting well into existing workflows without requiring full platform overhaul.

  • Pharma company seeking long-term, large-scale drug development partnership
    Pick: Isomorphic Labs

    Isomorphic Labs' Drug Design Engine, built on AlphaFold, is ideal for massive lead optimization with digital biology, backed by $600M+ funding and partnerships with Novartis and Johnson & Johnson.

  • AI-driven drug discovery startup needing synthesis-aware design
    Pick: PostEra

    PostEra's transparent AI and active learning help startups gather informative experimental data efficiently, provided they have synthesis capabilities.

  • Research institution exploring digital biology frontiers
    Pick: Isomorphic Labs

    Isomorphic Labs' AlphaFold-based models are at the cutting edge of digital biology, though access requires a deep research collaboration.

Frequently Asked Questions

PostEra vs Isomorphic Labs: which should you choose?

Choose PostEra if your team needs synthesis-aware medicinal chemistry with active learning and transparent partnership track record. Choose Isomorphic Labs if you are a large pharma seeking an AlphaFold-powered, simulation-first partner for ambitious discovery programs—but be prepared for a full collaboration model with higher barriers to entry.

Do both tools require a partnership to use?

Yes, both PostEra and Isomorphic Labs operate on a partnership model with contact-based pricing, not as standalone software.

Which one is better for small molecule design?

PostEra is more specialized in medicinal chemistry with retrosynthesis and multi-property optimization, making it better suited for small molecule drug discovery.

Is AlphaFold available through Isomorphic Labs?

Isomorphic Labs builds on AlphaFold but uses proprietary models in its Drug Design Engine; AlphaFold itself is available separately through DeepMind.

Can I use PostEra without a chemistry team?

No, PostEra is designed for medicinal chemists and requires human-in-the-loop expertise.

What is the latest funding news for Isomorphic Labs?

Isomorphic Labs raised $600M in March 2025 and closed a Series B in February 2026.

Does PostEra have any recent announcements?

No recent news was captured for PostEra; the latest known milestone is the Pfizer partnership expansion in January 2025.

Which tool is more accessible for startups?

PostEra is more accessible as it integrates with existing synthesis workflows, while Isomorphic Labs requires large-scale pharma partnerships.

Are the AI models transparent in both tools?

PostEra emphasizes transparent AI with validated partnerships and publications; Isomorphic Labs does not detail transparency practices.

More PostEra or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026